These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30896559)

  • 1. Examining Causes and Prevention Strategies of Adverse Events in Deceased Hospital Patients: A Retrospective Patient Record Review Study in the Netherlands.
    Smits M; Langelaan M; de Groot J; Wagner C
    J Patient Saf; 2021 Jun; 17(4):282-289. PubMed ID: 30896559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events and potentially preventable deaths in Dutch hospitals: results of a retrospective patient record review study.
    Zegers M; de Bruijne MC; Wagner C; Hoonhout LH; Waaijman R; Smits M; Hout FA; Zwaan L; Christiaans-Dingelhoff I; Timmermans DR; Groenewegen PP; van der Wal G
    Qual Saf Health Care; 2009 Aug; 18(4):297-302. PubMed ID: 19651935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events at the end of life of hospital patients with or without a condition relevant for palliative care: a nationwide retrospective record review study in the Netherlands.
    Schouten B; van Schoten SM; Bijnsdorp FM; Merten H; Nanayakkara PWB; Reyners AKL; Francke AL; Wagner C
    BMC Palliat Care; 2024 Jun; 23(1):145. PubMed ID: 38858703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication-related adverse events during hospitalization: a retrospective patient record review study in The Netherlands.
    Damen NL; Baines R; Wagner C; Langelaan M
    Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):32-39. PubMed ID: 27193415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence, root-causes, and outcomes of adverse events in surgical units: implication for potential prevention strategies.
    Zegers M; de Bruijne MC; de Keizer B; Merten H; Groenewegen PP; van der Wal G; Wagner C
    Patient Saf Surg; 2011 May; 5():13. PubMed ID: 21599915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The occurrence, types, consequences and preventability of in-hospital adverse events - a scoping review.
    Schwendimann R; Blatter C; Dhaini S; Simon M; Ausserhofer D
    BMC Health Serv Res; 2018 Jul; 18(1):521. PubMed ID: 29973258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct medical costs of adverse events in Dutch hospitals.
    Hoonhout LH; de Bruijne MC; Wagner C; Zegers M; Waaijman R; Spreeuwenberg P; Asscheman H; van der Wal G; van Tulder MW
    BMC Health Serv Res; 2009 Feb; 9():27. PubMed ID: 19203365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in adverse event rates in hospitals over time: a longitudinal retrospective patient record review study.
    Baines RJ; Langelaan M; de Bruijne MC; Asscheman H; Spreeuwenberg P; van de Steeg L; Siemerink KM; van Rosse F; Broekens M; Wagner C
    BMJ Qual Saf; 2013 Apr; 22(4):290-8. PubMed ID: 23293136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventable and mitigable adverse events in cancer care: Measuring risk and harm across the continuum.
    Lipitz-Snyderman A; Pfister D; Classen D; Atoria CL; Killen A; Epstein AS; Anderson C; Fortier E; Weingart SN
    Cancer; 2017 Dec; 123(23):4728-4736. PubMed ID: 28817180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Incidence and Nature of Adverse Medical Device Events in Dutch Hospitals: A Retrospective Patient Record Review Study.
    Porte PJ; Smits M; Verweij LM; de Bruijne MC; van der Vleuten CPM; Wagner C
    J Patient Saf; 2021 Dec; 17(8):e1719-e1725. PubMed ID: 32168269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the incidence of adverse events in Portuguese hospitals: a contribution to improving quality and patient safety.
    Sousa P; Uva AS; Serranheira F; Nunes C; Leite ES
    BMC Health Serv Res; 2014 Jul; 14():311. PubMed ID: 25034870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Description of contributing factors in adverse events related to patient safety and their preventability].
    Guerra-García MM; Campos-Rivas B; Sanmarful-Schwarz A; Vírseda-Sacristán A; Dorrego-López MA; Charle-Crespo Á
    Aten Primaria; 2018 Oct; 50(8):486-492. PubMed ID: 29183678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact and preventability of adverse events in Spanish public hospitals: results of the Spanish National Study of Adverse Events (ENEAS).
    Aranaz-Andrés JM; Aibar-Remón C; Vitaller-Burillo J; Requena-Puche J; Terol-García E; Kelley E; Gea-Velazquez de Castro MT;
    Int J Qual Health Care; 2009 Dec; 21(6):408-14. PubMed ID: 19841027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High risk of adverse events in hospitalised hip fracture patients of 65 years and older: results of a retrospective record review study.
    Merten H; Johannesma PC; Lubberding S; Zegers M; Langelaan M; Jukema GN; Heetveld MJ; Wagner C
    BMJ Open; 2015 Sep; 5(9):e006663. PubMed ID: 26346870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnic minority patients not at increased risk of adverse events during hospitalisation in urban hospitals in the Netherlands: results of a prospective observational study.
    van Rosse F; Essink-Bot ML; Stronks K; de Bruijne M; Wagner C
    BMJ Open; 2014 Dec; 4(12):e005527. PubMed ID: 25550290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scale, nature, preventability and causes of adverse events in hospitalised older patients.
    Merten H; Zegers M; de Bruijne MC; Wagner C
    Age Ageing; 2013 Jan; 42(1):87-93. PubMed ID: 23087046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Incidence and Preventability of Adverse Events in Older Acutely Admitted Patients: A Longitudinal Study With 4292 Patient Records.
    Schouten B; Merten H; Spreeuwenberg PMM; Nanayakkara PWB; Wagner C
    J Patient Saf; 2021 Apr; 17(3):166-173. PubMed ID: 33734205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in the rates of adverse events between hospitals and hospital departments.
    Zegers M; De Bruijne MC; Spreeuwenberg P; Wagner C; Van Der Wal G; Groenewegen PP
    Int J Qual Health Care; 2011 Apr; 23(2):126-33. PubMed ID: 21227956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can preventable adverse events be predicted among hospitalized older patients? The development and validation of a predictive model.
    Van De Steeg L; Langelaan M; Wagner C
    Int J Qual Health Care; 2014 Oct; 26(5):547-52. PubMed ID: 24990593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nature, occurrence and consequences of medication-related adverse events during hospitalization: a retrospective chart review in the Netherlands.
    Hoonhout LH; de Bruijne MC; Wagner C; Asscheman H; van der Wal G; van Tulder MW
    Drug Saf; 2010 Oct; 33(10):853-64. PubMed ID: 20812770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.